Bengtson, J R <br/><br/>
Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era.  [electronic resource] 

 -  Journal of the American College of Cardiology  Dec 1992 
 - 1482-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/0735-1097(92)90440-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Academic Medical Centers<br/>Age Factors<br/>Aged<br/>Angioplasty, Balloon, Coronary--standards<br/>Cardiac Catheterization<br/>Cardiac Output<br/>Cardiotonic Agents--therapeutic use<br/>Combined Modality Therapy<br/>Coronary Angiography<br/>Creatine Kinase--blood<br/>Decision Trees<br/>Female<br/>Follow-Up Studies<br/>Hospital Mortality<br/>Humans<br/>Intra-Aortic Balloon Pumping--standards<br/>Isoenzymes<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--complications<br/>Myocardial Reperfusion--methods<br/>North Carolina--epidemiology<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Shock, Cardiogenic--etiology<br/>Stroke Volume<br/>Survival Analysis<br/>Thrombolytic Therapy--standards<br/>Treatment Outcome<br/>Vasoconstrictor Agents--therapeutic use